HRT Financial LP's Form 4 filing
Shuttle Pharmaceuticals Holdings, Inc. (SHPH) · filed Jul 9, 2026
- Accession no.
- 0001475597-26-000144
- Filed
- Jul 9, 2026, 5:50 PM ET
- Trade date
- Jul 7-8, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market sales total $100.5K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| HRT Financial LPCIK 0001475597 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 7, 2026 | Common Stock | SSaleDisposed | −10,580 | $3.33 | −$35,231.4 | 70,805 | Direct | |
| Jul 8, 2026 | Common Stock | SSaleDisposed | −18,531 | $3.52 | −$65,229.12 | 52,274 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.